Lord, Abbett & Co
ACLX

Lord, Abbett & Co’s Arcellx ACLX Stock Holding History

Lord, Abbett & Co’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-449,634
Closed -$29.3M – 558
2025
Q4 		$29.3M Buy
449,634
+25,634
+6% +$2.04M 0.09% 217
2025
Q3 		$34.8M Buy
424,000
+86,424
+26% +$6.22M 0.1% 217
2025
Q2 		$22.2M Sell
337,576
-326,950
-49% -$20.4M 0.07% 265
2025
Q1 		$43.6M Sell
664,526
-310,306
-32% -$21M 0.16% 166
2024
Q4 		$74.8M Buy
974,832
+82,984
+9% +$7.17M 0.24% 118
2024
Q3 		$74.5M Buy
891,848
+18,004
+2% +$1.2M 0.24% 127
2024
Q2 		$48.2M Sell
873,844
-324,273
-27% -$17.6M 0.16% 170
2024
Q1 		$83.3M Buy
1,198,117
+1,550
+0.1% +$98.3K 0.27% 113
2023
Q4 		$66.4M Buy
1,196,567
+98,530
+9% +$4.44M 0.23% 126
2023
Q3 		$39.4M Sell
1,098,037
-167,335
-13% -$5.77M 0.15% 200
2023
Q2 		$40M Buy
1,265,372
+193,165
+18% +$7.38M 0.14% 213
2023
Q1 		$33M Buy
1,072,207
+523,710
+95% +$15.9M 0.12% 257
2022
Q4 		$17M Sell
548,497
-93,659
-15% -$2.15M 0.06% 368
2022
Q3 		$12.1M Buy
642,156
+135,162
+27% +$2.59M 0.04% 382
2022
Q2 		$9.17M Buy
+506,994
New +$6.54M 0.03% 421

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Lord, Abbett & Co's ACLX Position: Q1 2026 in Review

Lord, Abbett & Co sold out of Arcellx (ACLX) in Q1 2026, closing a stake of 449,634 shares — an estimated $29.3M sold.

Lord, Abbett & Co first reported a position in ACLX in Q2 2022 and held it in 15 quarters. The position peaked at $83.3M in Q1 2024. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Lord, Abbett & Co reported no remaining Arcellx position as of Q1 2026 after selling out during the quarter.
  • Lord, Abbett & Co sold 449,634 Arcellx shares in Q1 2026, an estimated $29.3M.
  • Lord, Abbett & Co first reported a position in Arcellx in Q2 2022 and held it in 15 quarters.
  • Lord, Abbett & Co's Arcellx position peaked at $83.3M in Q1 2024.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.